Page 9 of 20 Uses and Disclosures of Substance Use Disorder (SUD) Treatment Information • If we receive or maintain records about you from a SUD treatment program subject to 42 CFR part 2 (a “Part 2 Program”) through consent you provide the Part 2 Program to use or disclose the records, or testimony relaying the content of such records, they are given extra protection. These records shall not be used or disclosed in civil, criminal, administrative, or legislative proceedings against you unless you provide written consent, or a court order is issued after notice and an opportunity to be heard is provided by you or the holder of the records. Our Responsibilities • We are required by law to maintain the privacy and security of your protected health information. • We will let you know promptly if a breach occurs that may have compromised the privacy or security of your information. • We must follow the duties and privacy practices described in this notice and give you a copy of it. • We will not use or share your information other than as described here unless you tell us we can in writing. If you tell us we can, you may change your mind at any time. Let us know in writing if you change your mind. For more information see: www.hhs.gov/hipaa/for-individuals/guidance-materials-for-consumers/index.html. Changes to the Terms of this Notice We can change the terms of this notice, and the changes will apply to all information we have about you. The new notice will be available upon request, on our web site (if applicable), and we will mail a copy to you. Other Instructions for Notice 2/11/2026 Andrea Everage 1999 Harrison St, 9th Floor Oakland, California United States 94612-3520 510-808-2016 aeverage@meyersnave.com

Important Legal Notices - Medicare Information - Page 9 Important Legal Notices - Medicare Information Page 8 Page 10